Khush Mehta joined CardioDx in May 2016 as the President & Chief Executive Officer, and a member of the Board of Directors. Before CardioDx, Khush served as the Global Head of Healthcare Enterprise Solutions at Siemens where he had full-line responsibility for a multi-billion-dollar portfolio of managed services and solutions contract.
Khush earned Bachelor and Master of Commerce and Economics at the Sydenham College in Mumbai, India and an M.B.A. in Competitive Strategies and International Finance from Yale.
CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient through the fusion of genomics, biostatistics, and both cardiology and primary care medicine. Corus CAD is the only blood test that, along with a clinical assessment, can quickly, accurately, and safely help clinicians rule out obstructive coronary artery disease (CAD) in symptomatic patients.
Ajit Singh focuses on early-stage Technology and Life Science investments. He currently represents Artiman on the boards of Aditazz, CardioDx, Click Diagnostics, CORE Diagnostics, MedECube and OncoStem. A Consulting Professor in the School of Medicine at Stanford University, Ajit has two published books and five patents under his belt.
Coronary Artery Disease Detection